Talking Transfusion: The Transfusion Evidence Round-Up Podcast

Welcome to this special quarterly edition of the Transfusion Evidence Round-Up, produced by the International Society of Blood Transfusion (ISBT) and the Transfusion Evidence Library (TEL). In honor of International Childhood Cancer Day, we’ve partnered with the ISBT Cellular Therapies Working Group to bring you a joint Round-Up highlighting the latest evidence in both Transfusion Medicine and Cell Therapy.In this episode, we explore top research shaping pediatric hematology and stem cell transplantation, including the impact of minimal residual disease on outcomes in childhood acute lymphoblastic leukemia from the FORUM Trial. We also highlight advances in TCRαβ/CD19-depleted hematopoietic stem cell transplantation, second transplants for relapsed acute myeloid leukemia, and outcomes following CAR-T therapy in children and young adults.Whether you’re a transfusion specialist, cell therapy researcher, or healthcare professional interested in pediatric oncology, this top-ten selection of articles offers insights that cross the boundaries of both fields.

Did you miss the Blood 2025 and ISBT Perth 2025 Congress? Or perhaps you joined us in Perth and are now looking to dive deeper or revisit the highlights?In this podcast episode, Allison Mo (hematologist from Melbourne, Australia) and Catherine Kimber and Susan Brunskill (from the Systematic Reviews Initiative, UK) sit down with two special guests, Pierre Tiberghien and Aaron Hess, to reflect on their experiences at the joint Blood and ISBT Congress held in Perth in October 2025.Our guests share their perspectives, memorable moments, and key takeaways from the event. Pierre Tiberghien is the ISBT President and a Professor of Medicine at the Université de Franche-Comté. Aaron Hess joins us as a transfusion medicine specialist with the New Zealand Blood Service, offering valuable insights into his time at the congress.